77168-22-0

Usage

Uses

Used in Pharmaceutical Industry:
2-[(1H-benzimidazol-2-ylsulfanyl)acetyl]-N-butylhydrazinecarbothioamide is used as a precursor in drug development for its potential therapeutic properties. 2-[(1H-benzimidazol-2-ylsulfanyl)acetyl]-N-butylhydrazinecarbothioamide's structural elements may contribute to its efficacy as an anti-cancer, anti-bacterial, or anti-inflammatory agent, depending on further research and clinical studies.
Used in Cancer Treatment:
In the field of oncology, 2-[(1H-benzimidazol-2-ylsulfanyl)acetyl]-N-butylhydrazinecarbothioamide is considered for its potential as an anti-cancer agent. Its complex structure may allow it to target specific cellular pathways or mechanisms involved in cancer progression, offering a new avenue for treatment options.
Used in Antibacterial Therapies:
2-[(1H-benzimidazol-2-ylsulfanyl)acetyl]-N-butylhydrazinecarbothioamide may also be utilized in the development of new antibacterial drugs, given its capacity to interact with biological systems. This could be particularly relevant in the context of increasing antibiotic resistance, where novel compounds are urgently needed.
Used in Anti-inflammatory Medications:
Given the potential for modulating immune responses, 2-[(1H-benzimidazol-2-ylsulfanyl)acetyl]-N-butylhydrazinecarbothioamide could be explored for its anti-inflammatory properties, which may be beneficial in treating a range of inflammatory conditions.
Further research is essential to fully understand the properties and potential uses of 2-[(1H-benzimidazol-2-ylsulfanyl)acetyl]-N-butylhydrazinecarbothioamide, including its safety profile, efficacy, and optimal delivery methods for clinical applications.